Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma

por Liu, Chao-Qun, Xu, Jing, Zhou, Zhong-Guo, Jin, Li-Lian, Yu, Xing-Juan, Xiao, Gang, Lin, Jie, Zhuang, Shi-Mei, Zhang, Yao-Jun, Zheng, Limin
Publicado 2018

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma

por Xiao, Gang, Jin, Li-Lian, Liu, Chao-Qun, Wang, Yong-Chun, Meng, Ya-Ming, Zhou, Zhong-Guo, Chen, Jing, Yu, Xing-Juan, Zhang, Yao-Jun, Xu, Jing, Zheng, Limin
Publicado 2019

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer

por Chen, Jing, Sun, Hong-Wei, Yang, Yan-Yan, Chen, Hai-Tian, Yu, Xing-Juan, Wu, Wen-Chao, Xu, Yi-Tuo, Jin, Li-Lian, Wu, Xiao-Jun, Xu, Jing, Zheng, Limin
Publicado 2021